HematoCare: Feasibility of a Survivorship Care Plan for Hematologic Cancer Patients Undergoing HSCT

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorAzienda USL Reggio Emilia - IRCCS

About this trial

This is a feasibility study to implement a Survivorship Care (SC) Plan for patients with hematologic cancer undergoing hematopoietic stem cell transplantation (HSCT). The study evaluates if the intervention is feasible within the Italian national health system, focusing on retention rates, quality of life, unmet needs and caregiver burden

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Patients with hematologic cancer candidates for HSCT (autologous or allogeneic) and their informal caregivers

Able to provide informed consent

Able to communicate in Italian

Disqualifiers

Patients or caregivers with comorbidities hindering participation (e.g., significant cognitive limitations)

Trial design

Design model

Single group

Treatments tested in this trial

  • Survivorship Care (SC) Plan

    Other intervention

    The SC plan is tailored to the patient's needs and accounts for the appropriate treatment summary, follow-up recommendations and advice addressed to health promotion and to the management of symptoms and treatments' side-effects. Upon discharge, patients will be followed up by a care coordinator (oncology/basic nurse, physical therapist, or occupational therapist) who will assess their QoL and perceived needs. Based on these results, the SC plan will be integrated with appropriate referral to educational resources, services, and/or sing-post to facilities available in the hospital and/or community.

Treatment groups

40 Participants
are divided into 1 treatment group
Group A: Survivorship Care PlanOther 1 intervention

Trial outcomes

Primary outcomes

1

Retention Fraction

The percentage of enrolled patients who complete at least 70% of the scheduled assessments

Time frame
6 months

Secondary outcomes

1

Quality of Life assessed by EORTC QLQ-C30

Quality of life will be assessed using the EORTC QLQ-C30 questionnaire, a 30-item multidimensional instrument including a global health status scale, five functional scales (physical, role, emotional, cognitive, and social functioning), three symptom scales (fatigue, pain, and nausea/vomiting), and six single items assessing additional symptoms. Higher scores indicate better quality of life for global health status and functional scales, but worse symptom severity for symptom scales. The minimal clinically important difference (MCID) is estimated between 5 and 10 points.

Time frame
baseline, 100days, 6 months
2

Caregiver Burden assessed by Caregiver Reaction Assessment (CRA)

Measured via the Caregiver Reaction Assessment (CRA) scale. It consists of 24 item evaluating five domains: impact on schedule, finances, lack of family support, health, and caregiver esteem. Domain scores are calculated as the mean of the corresponding items and range from 1 to 5. Higher scores represent a greater impact on the caregiver's life in each specific domain, except for 'Caregiver Esteem', where higher scores reflect a more positive experience

Time frame
baseline, 100 days, 6 months
3

Perceived needs of patients

Perceived needs of patients assessed through Supportive Care Needs Survey - Short Form, 34 items (SCNS-SF34), a validated self-report instrument assessing perceived supportive care needs of adult cancer patients across five domains: psychological, health system and information, physical and daily living, patient care and support, and sexuality. Scoring and Interpretation: Each item is scored on a 5-point Likert scale ranging from 1 to 5, where: 1. means 'No need' (satisfied) 2. means 'No need' (already met) 3, 4, and 5 indicate 'Unmet need' (low, moderate, and high, respectively). For each domain, the raw scores are transformed into a standardized scale from 0 to 100. Higher scores indicate a greater level of unmet needs, meaning that the patient requires more support in that specific area.

Time frame
baseline, 100 days, 6 months
4

Usability of data collection - Patient Perspective

This assessment will be conducted from the perspectives of patients using structured questionnaires developed for this study. The implementation outcomes of acceptability, appropriates, adoption, and feasibility will be investigated. Specifically, the questionnaire will assess the perceived length of the question battery (burden), potential item redundancy, and the overall relevance and sensitivity of the topics addressed in relation to the post-transplant experience.

Time frame
6 months

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.